Pay in 4 interest-free payments of $6.60 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Our fast shipping helps maintain peptide viability and support researchers with faster experimental timelines
Most research applications utilize the following framework: Initial Research Phase: Total blend concentration: 12mg per vial Reconstitution volume: 2-3mL bacteriostatic water Research dosage range: 100-300mcg per administration Frequency: 1-2 times daily during active research periods Advanced Research Protocols: tesa component : 50-100mcg per dose CJC1295 component : 100-200mcg per dose Ipamorelin component : 100-300mcg per dose Combined cjc1295 ipamorelin dosage : 200-500mcg total The tesa cjc1295 ipamorelin 12mg blend reconstitution process requires precise measurement and sterile technique to maintain research integrity
Compatibility: Avoid simultaneous use in the same formula with strong chelating agents, acids, allantoin, niacinamide, arbutin, carbomer
Per-Peptide HPLC and LC-MS Verification on Every Batch Pre-committed acceptance criteria for both peptides get logged before each synthesis run begins, with purity and identity scored independently for the BPC-157 fraction and the TB-500 fraction rather than against a combined chromatogram
Supporting documentation should: State when the procedure was started
We are known primarily for having a wide range of quality products and on-time delivery
